Trials / Terminated
TerminatedNCT00673270
Effects of Fludrocortisone and Hydrocortisone in Healthy Volunteers With Aldosterone Induced Suppression
Hemodynamic and Biological Effects of Fludrocortisone and Hydrocortisone, in Healthy Volunteers With Aldosterone Induced Suppression
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Rennes University Hospital · Academic / Other
- Sex
- Male
- Age
- 20 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
Septic shock (associated with relative adrenal insufficiency) is characterized by decreased arterial responsiveness to catecholamines. The association of hydrocortisone and fludrocortisone has demonstrated an improvement in survival in septic shock patients. If hydrocortisone has shown to increase vascular responsiveness, the role of fludrocortisone remains to be elucidated. The purpose of our study is to investigate the effect of a physiological dose of fludrocortisone and/or hydrocortisone on phenylephrine-mean arterial pressure dose-response relationship in healthy volunteers with aldosterone suppression induced by intravenous sodium loading.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fludrocortisone | 50 µg of fludrocortisone per os |
| DRUG | Hydrocortisone | 50 mg of intravenous hydrocortisone |
| DRUG | Placebo of Fludrocortisone | Tablet of placebo of Fludrocortisone |
| DRUG | Placebo of Hydrocortisone | 2 ml of isotonic saline solution |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2008-10-01
- Completion
- 2009-03-01
- First posted
- 2008-05-07
- Last updated
- 2012-03-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00673270. Inclusion in this directory is not an endorsement.